Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 SEK | -2.78% | -13.37% | -43.73% |
Apr. 25 | AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | Jan Lundberg acquired an unknown minority stake in AlzeCure Pharma AB (OM : ALZCUR). | CI |
Sales 2024 * | - | Sales 2025 * | 60 5.55 | Capitalization | 109M 10.05M |
---|---|---|---|---|---|
Net income 2024 * | -46M -4.25M | Net income 2025 * | -7M -647K | EV / Sales 2024 * | - |
Net cash position 2024 * | 42.5M 3.93M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1,810,871 x |
P/E ratio 2024 * |
5.83
x | P/E ratio 2025 * |
-1.59
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.43% |
1 day | -2.78% | ||
1 week | -13.37% | ||
Current month | -7.41% | ||
1 month | -2.23% | ||
3 months | -43.55% | ||
6 months | -58.33% | ||
Current year | -43.73% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Jönsson
CEO | Chief Executive Officer | 56 | 20-01-07 |
Johan Sandin
FOU | Founder | 54 | 16-11-21 |
Birgitta Lundvik
DFI | Director of Finance/CFO | 57 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 16-12-31 | |
Ragnar Linder
BRD | Director/Board Member | 71 | 16-12-31 |
Ellen Donnelly
BRD | Director/Board Member | 50 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.75 | -2.78% | 76,539 |
24-05-02 | 1.8 | -4.76% | 71,638 |
24-04-30 | 1.89 | -1.56% | 11,135 |
24-04-29 | 1.92 | -4.95% | 89,919 |
24-04-26 | 2.02 | -1.46% | 191,004 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 11:18 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.73% | 10.06M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ALZCUR Stock